• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION, INC CHLORAPREP UNKNOWN; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION, INC CHLORAPREP UNKNOWN; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reaction (2414)
Event Date 02/11/2021
Event Type  Injury  
Manufacturer Narrative
Pr (b)(4).Initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).No additional information was provided by (b)(6) did reach out to obtain more information with no success.Should additional information be available in the future, the complaint will be re-opened and investigated.All complaints are reviewed during monthly quality/safety meetings.In addition, complaints are trended at monthly quality data analyst meetings and quarterly plant management review meetings.
 
Event Description
It was reported application site hypersensitivity to chloraprep.Initial information was processed with additional information received on 05-jan-2021.This solicited report received from health care professional and patient via ppsphn002323: sp services accredo, concerned a [omitted], and height was not reported.The patient's concurrent conditions included primary pulmonary hypertension.The patient was treated with macitentan (tablet, oral, batch number: zm021b0101 expiry: 30-nov-2023) 10 mg, 1 time every 1 day, therapy dates were not reported for primary pulmonary hypertension non-company suspect drugs.Included: chlorhexidine gluconate/isopropanol (form of admin, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported; and treprostmil sodium (form of admin unknown, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported, and dose, frequency, and therapy dates were not reported for an unspecified indication.No concomitant medications were reported on an unspecified date, the patient changed from remodulm subcutaneous to remodulin intravenous (iv) therapy the patient reported she was doing just as good at current of remodulin iv as she did with the subcutaneous dose.On an unspecified date, the patient had severe subcutaneous site pam which impacted her quality of life.The patient reported she also had occasional headache and nausea with remodulin iv but there was no leg pain like she did with the subcutaneous dose the patient reported sensitivity to chloroprep and requested iodine dressing change kits on an unspecified date, the surgeon placed patient's hickman m the wrong place so the patient will go back to the hospital on 08-jan-2021 to have it replaced.The action taken with macitentan, treprostinil sodium, and chlorhexidine gluconate/isopropanol was not reported.The outcome of the severe subcut site pam, occasional headache, nausea with iv, sensitivity to chloraprep, surgeon placed hickman in the wrong place and leg pain was not reported.The reporter provided no causality assessment.Company causality between macitentan, and surgeon placed hickman in the wrong place, severe subcut site pain, nausea with iv, sensitivity to chloraprep, and leg pam was not related, and between macitentan, and occasional headache was related.This report was non-senous.This case, involving the same patient is linked to (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP UNKNOWN
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
Manufacturer (Section G)
CAREFUSION, INC
75 n. fairview drive
vernon hills IL 60061
Manufacturer Contact
anna wehrheim
75 n. fairview drive
vernon hills, IL 60061
8015652341
MDR Report Key11365630
MDR Text Key244055688
Report Number3004932373-2021-00069
Device Sequence Number1
Product Code KXF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/11/2021
Initial Date FDA Received02/23/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight112
-
-